New drugs for Old: Heparin and its mimetics
-
Chair(s):
Prof. Clive Page,
Director, Sackler Institute of Pulmonary Pharmacology,King's College London, London, United KingdomDr. John Hogwood
Senior Scientist,National Institute for Biological Standards and Control, Potters Bar, United Kingdom -
Session description:
Nebulised heparin for the treatment of respiratory diseases
Professor Janis Shute
Professor of Respiratory Pharmacology, University of Portsmouth, Portsmouth, United KingdomProspective medical applications for sulfated polysaccharides of marine origin
Professor Paulo Mourão
Professor of Medical Biochemistry, Universidade Federal do Rio de Janeiro, Rio de Janeiro, BrazilRecent Progress in Recombinant Heparin
Dr Charles Glass
President, TEGA Therapeutics Inc. , San Diego, The United States of AmericaNon-anticoagulant heparins as potential anti-inflammatory and anti-complementary agents
Dr John Hogwood
Senior Scientist, National Institute for Biological Standards and Control, Potters Bar, United KingdomSynthetic heparan sulfate mimetics
Professor Deirdre Coombe
Head of Molecular Immunology Laboratory, Curtin University, Perth, Australia
Speakers
-
Dr Charles GlassPresident,TEGA Therapeutics Inc. , San Diego, The United States of America
-
Dr John HogwoodSenior Scientist,National Institute for Biological Standards and Control, Potters Bar, United Kingdom
-
Prof Janis ShuteProfessor of Respiratory Pharmacology,University of Portsmouth, Portsmouth, United Kingdom
-
Professor Deirdre Coombe Head of Molecular Immunology Laboratory,Curtin University, Perth, AustraliaProfessor Deirdre CoombeHead of Molecular Immunology Laboratory,Curtin University, Perth, Australia
Leave A Comment